Personalized T-cell therapy for advanced solid tumors
Part of Cancer clinical trials.
This early-phase study tests a personalized treatment made from your own immune cells to attack solid tumors that have not responded to standard care. If you qualify, the team will collect blood cells, prepare the therapy, and give it back to you with close monitoring for safety and early signs of benefit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 to 70 years old, and you choose to join the study after understanding it
- You have a solid cancer that has failed standard treatment or has no standard option
- You have at least one tumor spot that doctors can safely target (a lesion that can be punctured)
- Your body is strong enough for treatment (blood counts, liver/kidney function, and clotting are within allowed ranges)
- You can provide blood for cell collection, and doctors can successfully make the personalized therapy from it
- You can use effective birth control during the study and for a set time after treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a personalized immune-cell treatment (TCR-T cells) made from your own immune cells. You may qualify if you have a solid tumor that shows a specific target on tumor cells and your body type (HLA-A2) matches what the therapy needs.
This study tests a personalized treatment made from your own immune cells (T cells) that are re-engineered to recognize and attack your specific tumor. It is for people with advanced solid tumors that have not responded to other treatments. If you qualify, you will have a blood draw and a tumor sample collected to create your own custom T cell therapy.
This trial tests a personalized treatment made from your own immune cells (T-cells) that are modified to attack your tumor. It is for people with advanced solid tumors that have not responded to standard treatments.
This trial tests a personalized cell therapy that uses your own immune cells (T-cells) specially modified to target your tumor. It is for people with advanced solid tumors who have run out of standard treatment options.
This trial tests a personalized therapy made from your own immune cells. Doctors will take a sample of your tumor, find cells that recognize your cancer, grow them in the lab, and give them back to you to fight your advanced solid tumor that has not responded to other treatments.
This early-phase study tests personalized immune cells (T cells) made from your own tumor and blood to treat advanced solid cancers. It may help your immune system recognize and attack your tumor, especially if standard treatments no longer work.
Hear when a new Refractory Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.